Aetna has agreed to settle a lawsuit that accused the health insurer of discriminating against LGBTQ+ customers in need of fertility treatment.
Under the deal announced Friday, the insurer will make coverage of artificial insemination standard for all customers nationally and work to ensure that patients have equal access to more expensive in-vitro fertilization procedures, according to the National Women’s Law Center, which represented plaintiffs in the case.
Aetna, the health insurance arm of CVS Health Corp., covers nearly 19 million people. This includes employer-sponsored health insurance.
The insurer will set aside a $2 million fund to reimburse people who had coverage from some of its commercial insurance plans in New York and were denied reimbursement for artificial insemination, a procedure in which sperm is placed directly in a woman’s uterus.
A CVS Health spokesman said the company was pleased to resolve the case and “committed to providing quality care to all individuals regardless of their sexual orientation or gender identity.”
A federal judge still must approve the deal.
The settlement stems from a 2021 lawsuit filed in a federal court in New York. Emma Goidel said she and her spouse, Ilana Caplan, spent more than $50,000 on fertility treatments to conceive their second child after Aetna rejected several requests for coverage.
Aetna’s decision to cover fertility treatments for LGBTQ individuals signifies a step towards equality. Notably, it aligns with efforts to promote LGBTQ rights in healthcare. Additionally, it fosters a more inclusive healthcare environment.
Consequently, LGBTQ individuals can access vital reproductive healthcare services without discrimination. Furthermore, it reinforces the importance of corporate responsibility in advancing social justice causes. In conclusion, Aetna Fertility Coverage stands as a testament to progress towards equitable healthcare access for all.
read more
image source
